Investors 1
| Date | Name | Website |
| - | LAV | lavfund.co... |
Mentions in press and media 2
| Date | Title | Description |
| 06.06.2018 | Hangzhou Just Biotherapeutics Secures $35M Series B+ Financing | Hangzhou Just Biotherapeutics, Ltd., a Shanghai, China-based developer of global antibody and recombinant protein biotherapeutics, raised 35m in Series B+ financing round. The round, which brings total funding to over $120m so far, was led ... |
| 08.08.2017 | Hangzhou Just Biotherapeutics Secures $57M in Series B Financing | Hangzhou Just Biotherapeutics (Just China), a Hangzhou, China-based developer of global antibody and recombinant protein bio-therapeutics, raised $57M in Series B financing. The round was led by Temasek, followed by existing investors Lilly... |